Common breast cancer mutations in the PIK3CA, GATA3 and KMT2C genes are significantly more prevalent in ER-positive/HER2-negative/low proliferation/luminal A cancers compared to the claudin-low group (Table 8). This evidence concerns the gene ESR1 and breast cancer.